The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021)

The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021)

Authors

  • Seyed-Hossein Hosseini-Berneti Student Research Committee, Babol University of Medical Science, Babol
  • Mohsen Karami Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Department of Parasitology and Mycology, Babol University of Medical Sciences, Babol
  • Fatemeh Bayani Department of Health, Health Systems Research, Health Research Institute, Babol University of Medical Sciences, Babol
  • Mehdi Moghaddasi Department of Health, Health Systems Research, Health Research Institute, Babol University of Medical Sciences, Babol
  • Ozra Babazade Department of Health, Health Systems Research, Health Research Institute, Babol University of Medical Sciences, Babol
  • Pouyan Ebrahimi Student Research Committee, Babol University of Medical Science, Babol https://orcid.org/0000-0003-2654-2169
  • Hossein-Ali Nikbakht Social Determinants of Health Research Center, Health Research Institute, Department of Biostatistics & Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol

Keywords:

Respiratory system, lung, trends, mortality, Iran

Abstract

Background: In Iran, cancers are known as the second leading cause of death, among which respiratory system cancers are particularly important because lung cancer is the second most common cause of death in this country. This study aimed to estimate the crude and age-standardized mortality and its trends during 9 years in the northern city of Iran, Babol.
Methods: In this cross-sectional study, all the recorded deaths due to respiratory system cancers in Babol during the years 2013-2021 on the Classification of Causes of Deaths and Death Registration System of Babol University of Medical Sciences were taken into consideration, and the population estimate was based on the latest census. Finally, the crude and age-standardized rates of mortality and trends of cancer incidents were calculated.
Results: In general, 393 deaths with an overall mean age of 67.8±3.9 years have happened due to respiratory system cancers. The crude and standardized rates of respiratory system cancers increased from 6.5 and 5.5 per hundred thousand people in 2013 to 9.1 and 7.8 per hundred thousand people in 2021, respectively. With each decade in age, their trends increased significantly in men (p=0.024) and remained constant in women (p=0.262). In examining the trend of respiratory system cancers, we found an increasing trend for lung cancer and a constant trend for larynx and oropharynx cancers. There was also a decreasing trend for hypopharyngeal cancer.
Conclusions: The age-standardized rate and trend of respiratory system cancers are increasing. Therefore, it is important to prevent their prevalence by reducing the risk factors and increasing the general awareness of risks and timely diagnosis.

References

National Cancer Institute. What is cancer? 2021. Accessed: January 5, 2023. Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.

International Agency for Research on Cancer. Cancer today. Data visualization tools for exploring the global cancer burden in 2020. Accessed: January 6, 2023. Available from: https://gco.iarc.fr/today/home

Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J 2016;48:889-902.

Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res 2019;11:943.

Tu J, Inthavong K, Ahmadi G. The human respiratory system. In: Tu J, Inthavong K, Ahmadi G, editors. Computational fluid and particle dynamics in the human respiratory system. Dordrecht, Springer: 2013. p. 19-44.

Wikipedia [Internet]. Respiratory system. Accessed: January 30, 2023]. Available from: https://en.wikipedia.org/wiki/Respiratory_system

Bradley SH, Kennedy MP, Neal RD. Recognising lung cancer in primary care. Adv Ther 2019;36:19-30.

Ruano-Raviña A, Provencio M, Calvo de Juan V, Carcereny E, Moran T, Rodriguez-Abreu D, et al. Lung cancer symptoms at diagnosis: results of a nationwide registry study. ESMO Open 2020;5:e001021.

Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci 2021;22:8661.

Lemjabbar-Alaoui H, Hassan OU, Yang Y-W, Buchanan P. Lung cancer: Biology and treatment options. Biochim Biophys Acta 2015;1856:189-210.

Frille A, Hardavella G, Lee R. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. Breathe (Sheff) 2020;16:190322.

Rezapour A, Nargesi S, Mezginejad F, Kemmak AR, Bagherzadeh R. The economic burden of cancer in Iran during 1995-2019: a systematic review. Iran J Public Health 2021;50:35-45.

O'Hare B, Makuta I, Chiwaula L, Bar-Zeev N. Income and child mortality in developing countries: a systematic review and meta-analysis. J R Soc Med 2013;106:408-14.

Wikipedia [Internet]. Babol County. 2022. [in Persian]. Accessed: June 25, 2022. Available from: https://fa.wikipedia.org/wiki/%D8%B4%D9%87%D8%B1%D8%B3%D8%AA%D8%A7%D9%86_%D8%A8%D8%A7%D8%A8%D9%84

Khosravi A, Taylor R, Naghavi M, Lopez AD. Mortality in the islamic republic of Iran, 1964-2004. Bull World Health Organ 2007;85:607-14.

World Health Organization. International classification of diseases for oncology (ICD-O) – 3rd edition, 1st revision. 2013. Available from: https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology

Rajai N, Ghanbari A, Yoosefi M, Mohebi F, Mohajer B, Sheidaei A, et al. National and subnational trends in incidence and mortality of lung cancer in Iran from 1990 to 2016. Asia Pac J Clin Oncol 2020;16:129-36.

Zhao G, Li X, Lei S, Zhao H, Zhang H, Li J. Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Front Oncol 2022;12:947981.

Zou J, Sun T, Song X, Liu YM, Lei F, Chen MM, et al. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data. Respir Res 2022;23:90.

Hashemi SY, Momenabadi V, Faramarzi A, Kiani A. Trends in burden of chronic obstructive pulmonary disease in Iran, 1995-2015: findings from the global burden of disease study. Arch Public Health 2020;78:45.

Yang D, Liu Y, Bai C, Wang X, Powell CA. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett 2020;468:82-7.

Ebrahimi H, Aryan Z, Moghaddam SS, Bisignano C, Rezaei S, Pishgar F, et al. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir Med 2021;9:1030-49.

Costa SNdL, Fernandes FCGdM, Souza DLBd, Bezerra HdS, Santos EGdO, Barbosa IR. Incidence and mortality by larynx cancer in Central and South America. Rev Gaucha Enferm 2021;42:e20190469.

<a href="https://it.freepik.com/foto-gratuito/fare-della-diagnosi-un-compito-di-squadra-medici-che-esaminano-i-raggi-x-del-paziente_14817538.htm#query=respiratory%20system%20cancer&position=48&from_view=search&track=ais&uuid=ffb8525d-0c2e-43c5-9456-6047f23348b3">Immagine di prostooleh</a> su Freepik

Downloads

Published

18-12-2023

Issue

Section

Original Research Articles

How to Cite

1.
Hosseini-Berneti S-H, Karami M, Bayani F, Moghaddasi M, Babazade O, Ebrahimi P, et al. The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021). Multidiscip Respir Med [Internet]. 2023 Dec. 18 [cited 2024 Jul. 4];18(1). Available from: https://mrmjournal.org/index.php/mrm/article/view/929